Literature DB >> 17613546

Cancer genetics of epigenetic genes.

Ahmad Miremadi1, Mikkel Z Oestergaard, Paul D P Pharoah, Carlos Caldas.   

Abstract

The cancer epigenome is characterised by specific DNA methylation and chromatin modification patterns. The proteins that mediate these changes are encoded by the epigenetics genes here defined as: DNA methyltransferases (DNMT), methyl-CpG-binding domain (MBD) proteins, histone acetyltransferases (HAT), histone deacetylases (HDAC), histone methyltransferases (HMT) and histone demethylases. We review the evidence that these genes can be targeted by mutations and expression changes in human cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613546     DOI: 10.1093/hmg/ddm021

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  96 in total

Review 1.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

2.  Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Jing-Jing Zhang; Yi Zhu; Yan Zhu; Jun-Li Wu; Wen-Biao Liang; Rong Zhu; Ze-Kuan Xu; Qing Du; Yi Miao
Journal:  Clin Transl Oncol       Date:  2012-02       Impact factor: 3.405

Review 3.  p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies.

Authors:  Yogen Saunthararajah; Pierre Triozzi; Brian Rini; Arun Singh; Tomas Radivoyevitch; Mikkael Sekeres; Anjali Advani; Ramon Tiu; Frederic Reu; Matt Kalaycio; Ed Copelan; Eric Hsi; Alan Lichtin; Brian Bolwell
Journal:  Semin Oncol       Date:  2012-02       Impact factor: 4.929

Review 4.  Environmental epigenetics and its implication on disease risk and health outcomes.

Authors:  Shuk-Mei Ho; Abby Johnson; Pheruza Tarapore; Vinothini Janakiram; Xiang Zhang; Yuet-Kin Leung
Journal:  ILAR J       Date:  2012

5.  miRNA regulation of Sirtuin-1 expression in human astrocytoma.

Authors:  Sara Giovanna Romeo; Alfredo Conti; Francesca Polito; Chiara Tomasello; Valeria Barresi; Domenico La La Torre; Maria Cucinotta; Flavio Filippo Angileri; Marcello Bartolotta; Rosa Maria Di Giorgio; M'Hammed Aguennouz
Journal:  Oncol Lett       Date:  2016-08-05       Impact factor: 2.967

6.  Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma.

Authors:  Hiaki Sato; Takashi Oka; Yoko Shinnou; Takami Kondo; Kana Washio; Masayuki Takano; Katsuyoshi Takata; Toshiaki Morito; Xingang Huang; Maiko Tamura; Yuta Kitamura; Nobuya Ohara; Mamoru Ouchida; Koichi Ohshima; Kenji Shimizu; Mitsune Tanimoto; Kiyoshi Takahashi; Masao Matsuoka; Atae Utsunomiya; Tadashi Yoshino
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

7.  Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.

Authors:  Li Ning; Renata Jaskula-Sztul; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2008-06-18       Impact factor: 5.344

Review 8.  DNA methylation of cancer genome.

Authors:  Hoi-Hung Cheung; Tin-Lap Lee; Owen M Rennert; Wai-Yee Chan
Journal:  Birth Defects Res C Embryo Today       Date:  2009-12

9.  Epigenetic contributions to cancer metastasis.

Authors:  David I Rodenhiser
Journal:  Clin Exp Metastasis       Date:  2008-04-02       Impact factor: 5.150

Review 10.  Epigenetic Determinants of Cancer.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.